Patents by Inventor Lars Bo Laurenborg Hansen

Lars Bo Laurenborg Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nociceptin Analogues and Uses Thereof
    Publication number: 20080287478
    Abstract: The present invention relates to nociceptin analogues and uses thereof to modulate biological functions. In one aspect, the invention provides modified triazo-spiro compounds that include at least one specialized chemical group that is bound to the compounds. The invention has a wide range of applications including providing a new class of therapeutically useful aquatics.
    Type: Application
    Filed: May 21, 2004
    Publication date: November 20, 2008
    Inventors: Lars Bo Laurenborg Hansen, Bjarne Due Larsen, Christian Thorkildsen, Carsten Boye Knudsen
  • Compositions and methods for modulating connexin hemichannels
    Patent number: 7153822
    Abstract: Disclosed are compositions and methods for modulating hemichannel function in a cell, tissue or organ. The invention also relates to useful screens for detecting such compounds, particularly those capable of modulating connexin phosphorylation. Further provided are therapeutic methods for preventing or treating conditions impacted by undesired hemichannel function in a mammal such as heart arrhythmia.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: December 26, 2006
    Assignee: Wyeth
    Inventors: Peter Holme Jensen, Bjarne Due Larsen, Lars Bo Laurenborg Hansen, Jørgen Søberg Petersen, Soren Neve, Morten Schak Nielsen, Eddi Meier, Eva Steiness
  • Compositions and methods for modulating connexin hemichannels
    Publication number: 20040092429
    Abstract: Disclosed are compositions and methods for modulating hemichannel function in a cell, tissue or organ. The invention also relates to useful screens for detecting such compounds, particularly those capable of modulating connexin phosphorylation. Further provided are therapeutic methods for preventing or treating conditions impacted by undesired hemichannel function in a mammal such as heart arrhythmia.
    Type: Application
    Filed: January 29, 2003
    Publication date: May 13, 2004
    Applicant: Zealand Pharma A/S
    Inventors: Peter Holme Jensen, Bjarne Due Larsen, Lars Bo Laurenborg Hansen, Jorgen Soberg Petersen, Soren Neve, Morten Schak Nielsen, Eddi Meier, Eva Steiness